The 10-second takeaway
Comparing the upcoming quarter to the prior-year quarter, average analyst estimates predict Dolby Laboratories's revenues will drop -13.9% and EPS will wither -27.4%.
The average estimate for revenue is $209.9 million. On the bottom line, the average EPS estimate is $0.53.
Last quarter, Dolby Laboratories booked revenue of $207.9 million. GAAP reported sales were 5.1% lower than the prior-year quarter's $219.0 million.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
Last quarter, non-GAAP EPS came in at $0.57. GAAP EPS of $0.48 for Q3 were 13% lower than the prior-year quarter's $0.55 per share.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the preceding quarter, gross margin was 89.9%, 270 basis points better than the prior-year quarter. Operating margin was 32.7%, 740 basis points worse than the prior-year quarter. Net margin was 24.8%, 340 basis points worse than the prior-year quarter.
The full year's average estimate for revenue is $911.4 million. The average EPS estimate is $2.68.
The stock has a five-star rating (out of five) at Motley Fool CAPS, with 3,972 members out of 4,068 rating the stock outperform, and 96 members rating it underperform. Among 1,063 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 1,048 give Dolby Laboratories a green thumbs-up, and 15 give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Dolby Laboratories is hold, with an average price target of $48.14.
- Add Dolby Laboratories to My Watchlist.